• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌与憩室病

Probiotics and diverticular disease.

作者信息

Sheth Anish, Floch Martin

机构信息

Yale University School of Medicine, Section of Digestive Diseases, 40 Temple St, New Haven, CT 06510, USA.

出版信息

Nutr Clin Pract. 2009 Feb-Mar;24(1):41-4. doi: 10.1177/0884533608329230.

DOI:10.1177/0884533608329230
PMID:19244147
Abstract

Diverticular disease is one of the most common medical conditions affecting Western populations. Inflammatory complications are the most common manifestation of the disease and typically cause acute bouts of abdominal pain and fever. Chronic symptoms can also occur and can be mistakenly attributed to irritable bowel syndrome and rarely to inflammatory bowel disease. Alterations in peridiverticular bacterial flora are thought to play a role in the pathogenesis of diverticular inflammation. This article discusses the rationale and reviews the existing clinical data regarding the role of probiotics in the management of diverticular disease.

摘要

憩室病是影响西方人群的最常见疾病之一。炎症性并发症是该疾病最常见的表现,通常会引发急性腹痛和发热。慢性症状也可能出现,并且可能被误诊为肠易激综合征,很少被误诊为炎症性肠病。憩室周围细菌菌群的改变被认为在憩室炎的发病机制中起作用。本文讨论了相关原理,并回顾了有关益生菌在憩室病管理中作用的现有临床数据。

相似文献

1
Probiotics and diverticular disease.益生菌与憩室病
Nutr Clin Pract. 2009 Feb-Mar;24(1):41-4. doi: 10.1177/0884533608329230.
2
Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.肠易激综合征中的细菌菌群:在病理生理学中的作用及对治疗的意义
J Dig Dis. 2007 Feb;8(1):2-7. doi: 10.1111/j.1443-9573.2007.00277.x.
3
Role of probiotics in management of diverticular disease.益生菌在憩室病管理中的作用。
J Gastroenterol Hepatol. 2010 Dec;25(12):1827-30. doi: 10.1111/j.1440-1746.2010.06444.x.
4
Bacterial overgrowth as a cause of irritable bowel syndrome.细菌过度生长作为肠易激综合征的一个病因
Curr Opin Gastroenterol. 2006 Nov;22(6):669-73. doi: 10.1097/01.mog.0000245544.80160.46.
5
Clinical use of probiotics in the pediatric population.益生菌在儿科人群中的临床应用。
Nutr Clin Pract. 2009 Feb-Mar;24(1):50-9. doi: 10.1177/0884533608329298.
6
Treating irritable bowel syndrome with probiotics: the evidence.用益生菌治疗肠易激综合征:证据。
Proc Nutr Soc. 2010 May;69(2):187-94. doi: 10.1017/S002966511000011X. Epub 2010 Mar 18.
7
Diverticular disease and diverticulitis.憩室病和憩室炎。
Am J Gastroenterol. 2008 Jun;103(6):1550-6. doi: 10.1111/j.1572-0241.2008.01879.x. Epub 2008 May 13.
8
Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.益生菌与肠易激综合征:理论依据、作用机制及疗效
J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S123-5. doi: 10.1097/MCG.0b013e3181574393.
9
Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.益生菌与肠易激综合征:使用的理论依据及对现有证据的评估
Neurogastroenterol Motil. 2007 Mar;19(3):166-72. doi: 10.1111/j.1365-2982.2006.00879.x.
10
Inflammation and microflora.炎症与微生物群。
Gastroenterol Clin North Am. 2011 Mar;40(1):69-85. doi: 10.1016/j.gtc.2010.12.010.

引用本文的文献

1
Diverticular disease: update on pathophysiology, classification and management.憩室病:病理生理学、分类及管理的最新进展
Frontline Gastroenterol. 2023 Jul 27;15(1):50-58. doi: 10.1136/flgastro-2022-102361. eCollection 2024 Jan.
2
Preventing recurrent acute diverticulitis with pharmacological therapies.药物治疗预防复发性急性憩室炎。
Ther Adv Chronic Dis. 2013 Nov;4(6):277-86. doi: 10.1177/2040622313498809.
3
Epidemiology and pathophysiology of diverticular disease.憩室病的流行病学与病理生理学
Clin Colon Rectal Surg. 2009 Aug;22(3):141-6. doi: 10.1055/s-0029-1236157.